Literature DB >> 19374848

Membrane cholesterol content influences binding properties of muscarinic M2 receptors and differentially impacts activation of second messenger pathways.

Pavel Michal1, Vladimír Rudajev, Esam E El-Fakahany, Vladimír Dolezal.   

Abstract

We investigated the influence of membrane cholesterol content on preferential and non-preferential signaling through the M(2) muscarinic acetylcholine receptor expressed in CHO cells. Cholesterol depletion by 39% significantly decreased the affinity of M(2) receptors for [(3)H]-N-methylscopolamine ([(3)H]-NMS) binding and increased B(max) in intact cells and membranes. Membranes displayed two-affinity agonist binding sites for carbachol and cholesterol depletion doubled the fraction of high-affinity binding sites. In intact cells it also reduced the rate of agonist-induced receptor internalization and changed the profile of agonist binding from a single site to two affinity states. Cholesterol enrichment by 137% had no effects on carbachol E(max) of cAMP synthesis inhibition and on cAMP synthesis stimulation and inositolphosphates (IP) accumulation at higher agonist concentrations (non-preferred pathways). On the other hand, cholesterol depletion significantly increased E(max) of cAMP synthesis inhibition or stimulation without change in potency, and decreased E(max) of IP accumulation. Noteworthy, modifications of membrane cholesterol had no effect on membrane permeability, oxidative activity, protein content, or relative expression of G(s), G(i/o), and G(q/11) alpha subunits. These results demonstrate distinct changes of M(2) receptor signaling through both preferential and non-preferential G-proteins consequent to membrane cholesterol depletion that occur at the level of receptor/G-protein/effector protein interactions in the cell membrane. The significant decrease of IP accumulation by cholesterol depletion was also observed in cells expressing M(3) receptors and by both cholesterol depletion and enrichment in cells expressing M(1) receptors indicating relevance of reduced G(q/11) signaling for the pathogenesis of Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19374848      PMCID: PMC2675699          DOI: 10.1016/j.ejphar.2009.01.028

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  49 in total

1.  Quantitation of mRNAs for M(1) to M(5) subtypes of muscarinic receptors in rat heart and brain cortex.

Authors:  Alena Krejcí; Stanislav Tucek
Journal:  Mol Pharmacol       Date:  2002-06       Impact factor: 4.436

2.  Positive cooperativity in the binding of alcuronium and N-methylscopolamine to muscarinic acetylcholine receptors.

Authors:  S Tucek; J Musílková; J Nedoma; J Proska; S Shelkovnikov; J Vorlícek
Journal:  Mol Pharmacol       Date:  1990-11       Impact factor: 4.436

Review 3.  Ligand-selective receptor conformations revisited: the promise and the problem.

Authors:  Terry Kenakin
Journal:  Trends Pharmacol Sci       Date:  2003-07       Impact factor: 14.819

4.  Luteinizing hormone receptors translocate to plasma membrane microdomains after binding of human chorionic gonadotropin.

Authors:  Steven M L Smith; Ying Lei; Jingjing Liu; Mary E Cahill; Guy M Hagen; B George Barisas; Deborah A Roess
Journal:  Endocrinology       Date:  2006-01-12       Impact factor: 4.736

Review 5.  Lipid rafts and signal transduction.

Authors:  K Simons; D Toomre
Journal:  Nat Rev Mol Cell Biol       Date:  2000-10       Impact factor: 94.444

6.  Dual effects of muscarinic M(2) acetylcholine receptors on the synthesis of cyclic AMP in CHO cells: dependence on time, receptor density and receptor agonists.

Authors:  P Michal; M Lysíková; S Tucek
Journal:  Br J Pharmacol       Date:  2001-03       Impact factor: 8.739

7.  Allosteric modulation by persistent binding of xanomeline of the interaction of competitive ligands with the M1 muscarinic acetylcholine receptor.

Authors:  Jan Jakubík; Stanislav Tucek; Esam E El-Fakahany
Journal:  J Pharmacol Exp Ther       Date:  2002-06       Impact factor: 4.030

8.  Evidence for cross-talk between M2 and M3 muscarinic acetylcholine receptors in the regulation of second messenger and extracellular signal-regulated kinase signalling pathways in Chinese hamster ovary cells.

Authors:  David C Hornigold; Rajendra Mistry; Pamela D Raymond; Jonathan L Blank; R A John Challiss
Journal:  Br J Pharmacol       Date:  2003-04       Impact factor: 8.739

9.  The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints.

Authors:  Robert Fredriksson; Malin C Lagerström; Lars-Gustav Lundin; Helgi B Schiöth
Journal:  Mol Pharmacol       Date:  2003-06       Impact factor: 4.436

Review 10.  Lipid rafts: bringing order to chaos.

Authors:  Linda J Pike
Journal:  J Lipid Res       Date:  2003-02-01       Impact factor: 5.922

View more
  9 in total

1.  Platelet glycoprotein Ib beta/IX mediates glycoprotein Ib alpha localization to membrane lipid domain critical for von Willebrand factor interaction at high shear.

Authors:  Hongquan Geng; Guofeng Xu; Yali Ran; José A López; Yuandong Peng
Journal:  J Biol Chem       Date:  2011-04-20       Impact factor: 5.157

2.  Live-cell microscopy or fluorescence anisotropy with budded baculoviruses-which way to go with measuring ligand binding to M4 muscarinic receptors?

Authors:  Maris-Johanna Tahk; Jane Torp; Mohammed A S Ali; Dmytro Fishman; Leopold Parts; Lukas Grätz; Christoph Müller; Max Keller; Santa Veiksina; Tõnis Laasfeld; Ago Rinken
Journal:  Open Biol       Date:  2022-06-08       Impact factor: 7.124

3.  Functional expression of opioid receptors and other human GPCRs in yeast engineered to produce human sterols.

Authors:  Björn D M Bean; Colleen J Mulvihill; Riddhiman K Garge; Daniel R Boutz; Olivier Rousseau; Brendan M Floyd; William Cheney; Elizabeth C Gardner; Andrew D Ellington; Edward M Marcotte; Jimmy D Gollihar; Malcolm Whiteway; Vincent J J Martin
Journal:  Nat Commun       Date:  2022-05-24       Impact factor: 17.694

4.  Location and Cell-Type-Specific Bias of Metabotropic Glutamate Receptor, mGlu5, Negative Allosteric Modulators.

Authors:  Yuh-Jiin Ivy Jong; Steven K Harmon; Karen L O'Malley
Journal:  ACS Chem Neurosci       Date:  2019-10-28       Impact factor: 4.418

5.  Subtype differences in pre-coupling of muscarinic acetylcholine receptors.

Authors:  Jan Jakubík; Helena Janíčková; Alena Randáková; Esam E El-Fakahany; Vladimír Doležal
Journal:  PLoS One       Date:  2011-11-16       Impact factor: 3.240

6.  Membrane cholesterol access into a G-protein-coupled receptor.

Authors:  Ramon Guixà-González; José L Albasanz; Ismael Rodriguez-Espigares; Manuel Pastor; Ferran Sanz; Maria Martí-Solano; Moutusi Manna; Hector Martinez-Seara; Peter W Hildebrand; Mairena Martín; Jana Selent
Journal:  Nat Commun       Date:  2017-02-21       Impact factor: 14.919

Review 7.  Allosteric Modulation of GPCRs of Class A by Cholesterol.

Authors:  Jan Jakubík; Esam E El-Fakahany
Journal:  Int J Mol Sci       Date:  2021-02-16       Impact factor: 5.923

8.  Non-neuronal functions of the m2 muscarinic acetylcholine receptor.

Authors:  Wymke Ockenga; Sina Kühne; Simone Bocksberger; Antje Banning; Ritva Tikkanen
Journal:  Genes (Basel)       Date:  2013-04-02       Impact factor: 4.096

9.  Changes in Membrane Cholesterol Differentially Influence Preferential and Non-preferential Signaling of the M1 and M3 Muscarinic Acetylcholine Receptors.

Authors:  Pavel Michal; Esam E El-Fakahany; Vladimír Doležal
Journal:  Neurochem Res       Date:  2014-05-13       Impact factor: 3.996

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.